Brokerages predict that Sonendo, Inc. (NYSE:SONX – Get Rating) will report earnings per share (EPS) of ($0.57) for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for Sonendo’s earnings. The lowest EPS estimate is ($0.59) and the highest is ($0.53). The company is expected to issue its next quarterly earnings results on Monday, January 1st.
On average, analysts expect that Sonendo will report full-year earnings of ($2.19) per share for the current year, with EPS estimates ranging from ($2.28) to ($2.06). For the next year, analysts anticipate that the business will report earnings of ($1.52) per share, with EPS estimates ranging from ($1.56) to ($1.47). Zacks’ earnings per share calculations are a mean average based on a survey of sell-side research firms that follow Sonendo.
Sonendo (NYSE:SONX – Get Rating) last issued its quarterly earnings results on Wednesday, March 23rd. The company reported ($0.72) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.50) by ($0.22).
A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Bank of America Corp DE acquired a new position in Sonendo in the 4th quarter valued at $31,000. Northern Trust Corp acquired a new stake in shares of Sonendo during the 4th quarter worth $76,000. Cubist Systematic Strategies LLC acquired a new stake in shares of Sonendo during the 4th quarter worth $82,000. Point72 Asset Management L.P. acquired a new stake in shares of Sonendo during the 4th quarter worth $115,000. Finally, BlackRock Inc. acquired a new stake in shares of Sonendo during the 4th quarter worth $116,000. Institutional investors and hedge funds own 18.29% of the company’s stock.
Shares of SONX stock opened at $2.87 on Friday. The company has a debt-to-equity ratio of 0.37, a current ratio of 6.75 and a quick ratio of 6.19. The company has a 50-day moving average price of $4.55. Sonendo has a twelve month low of $2.60 and a twelve month high of $12.24.
About Sonendo (Get Rating)
Sonendo, Inc, a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment device for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure.
- Get a free copy of the StockNews.com research report on Sonendo (SONX)
- Array Technologies Stock Giving Another Ground Floor Entry
- UiPath Stock is Nearing Rock Bottom Down Here
- 3 Undervalued S&P 500 Stocks to Buy Now
- 3 Undervalued Easter Eggs to Watch For This Earnings Season
- Lululemon Rises On Wave Of Price Target Increases
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Sonendo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonendo and related companies with MarketBeat.com's FREE daily email newsletter.